1 American Academy of Pediatrics. Policy Statement. Section on Breastfeeding (2005) Breastfeeding and the use of human milk. Pediatrics 115, 496–506.
2 Agostoni, C, Braegger, C, Decsi, T, et al. (2009) Breast-feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 49, 112–125.
3 Howie, PW, Forsyth, JS, Ogston, SA, et al. (1990) Protective effects of breast feeding against infection. BMJ 300, 11–16.
4 Dewey, KG, Heining, MJ & Nommsen-Rivers, LA (1995) Differences in morbidity between breast fed and formula fed infants. Pediatrics 126, 696–702.
5 Quigley, MA, Kelly, YJ & Sacker, A (2007) Breastfeeding and hospitalization for diarrheal and respiratory infection in the United Kingdom Millennium Cohort Study. Pediatrics 199, e837–e842.
6 Turck, D, Grillon, C, Lachambre, E, et al. (2006) Adequacy and safety of an infant formula with a protein/energy ratio of 1·8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. J Pediatr Gastroenterol Nutr 43, 364–371.
7 Carnielli, VP, Luijendijk, IHT, Van Goudoever, JB, et al. (1996) Structural position and amount of palmitic acid in infant formulas: effects on fat, fatty acid, and mineral balance. J Pediatr Gastroenterol Nutr 23, 553–560.
8 Newburg, DS & Walker, WA (2007) Protection of the neonate by the innate immune system of developing gut and human milk. Pediatr Res 61, 2–8.
9 Bode, L (2006) Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr 136, 2127–2130.
10 Forchielli, ML & Walker, WA (2005) The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr 93, S41–S48.
11 Guggenbichler, JP, De Bettingnies-Dutz, A, Meissner, P, et al. (1997) Acidic oligosaccharides from neutral sources block adherence of E. coli on uroepithelial cells. Pharm Pharmacol Lett 7, 35–38.
12 Veereman-Wauters, G (2005) Application of prebiotics in infant foods. Br J Nutr 93, S57–S60.
13 Kuntz, S, Rudloff, S & Kunz, C (2008) Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and non-transformed intestinal cells. Br J Nutr 99, 462–471.
14 Moro, G, Minoli, I, Mosca, M, et al. (2002) Dosage related bifidogenic effects of galacto- and fructo-oligosaccharides in formula fed term infants. J Pediatr Gastroenterol Nutr 34, 291–295.
15 Eiwegger, T, Stahl, B, Schmitt, J, et al. (2004) Human milk derived oligosaccharides and plant derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res 56, 536–540.
16 Arslanoglu, S, Moro, GE & Boehm, G (2007) Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr 137, 2420–2424.
17 Arslanoglu, S, Moro, GE, Schmitt, J, et al. (2008) Early dietary intervention with a mixture of prebiotics oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 138, 1091–1095.
18 Kukkonen, K, Savilahti, E, Haahtela, T, et al. (2008) Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 122, 8–12.
19 Hœst, A, Koletzko, B, Dreborg, S, et al. (1999) Dietary products used in infants for treatment and prevention of food allergy. Arch Dis Child 81, 80–84.
20 Grüber, C, van Stuijvenberg, M, Mosca, F, et al. (2010) Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 126, 791–797.
21 Wald, ER, Dashefsky, B, Byers, C, et al. (1988) Frequency and severity of infections in day care. J Pediatr 112, 540–546.
22 Moecks, J, Koch, GG, Scott, M, et al. (2004) Measures of morbidity in clinical studies with recurrent skeletal complications. J Biopharm Stat 14, 415–437.
23 Zhao, YD (2006) Sample size estimation for the van Elteren test – a stratified Wilcoxon–Mann–Whitney test. Statist Med 26, 2675–2687.
24 Hosmer, DW, Lemeshow, S & May, S (2008) Other models and topics. In Applied Survival Analysis: Regression Modelling of Time-to-Event Data, , 2nd ed., pp. 286–351. New York: Wiley-Interscience.
25 Bruzzese, E, Volpicelli, M, Squeglia, V, et al. (2009) A formula containing galacto- and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: an observational study. Clin Nutr 28, 156–161.
26 Weizman, Z, Asli, G & Alsheiki, A (2005) Effect of a probiotics infant formula on infections in child care centres: comparison of two probiotics agents. Pediatrics 115, 5–9.
27 Jarvis, D & Burney, P (1998) ABC of allergies – the epidemiology of allergic disease. BMJ 316, 607–610.
28 Moro, G, Arslanoglu, S, Stahl, B, et al. (2006) A mixture of prebiotics oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 91, 814–819.
29 Kramer, MS, Chalmers, B, Hodnett, ED, et al. (2001) Promotion of Breastfeeding Intervention Trial (PROBIT) – a randomized trial in the Republic of Belarus. JAMA 285, 413–420.
30 Chantry, CJ, Howard, CR & Auinger, P (2006) Full breastfeeding duration and associated decrease in respiratory tract infection in US children. Pediatrics 117, 425–432.